In CLL, LAMs, also known as CLL-nurse like cells (NLCs), promote the survival and proliferation of cancer cells via the expression of the chemokines CXCL12 and CXCL13 and impairs treatment-mediated apoptosis (136). Here, CXCL12 is linked to B-cell chronic lymphocytic leukemia.